How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

140 results for

Tinea Cruris

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

2. Topical antifungal treatments for tinea cruris and tinea corporis. (PubMed)

Topical antifungal treatments for tinea cruris and tinea corporis. Tinea infections are fungal infections of the skin caused by dermatophytes. It is estimated that 10% to 20% of the world population is affected by fungal skin infections. Sites of infection vary according to geographical location, the organism involved, and environmental and cultural differences. Both tinea corporis, also referred to as 'ringworm' and tinea cruris or 'jock itch' are conditions frequently seen by primary care (...) doctors and dermatologists. The diagnosis can be made on clinical appearance and can be confirmed by microscopy or culture. A wide range of topical antifungal drugs are used to treat these superficial dermatomycoses, but it is unclear which are the most effective.To assess the effects of topical antifungal treatments in tinea cruris and tinea corporis.We searched the following databases up to 13th August 2013: the Cochrane Skin Group Specialised Register, CENTRAL in The Cochrane Library (2013, Issue 7

Full Text available with Trip Pro

2014 Cochrane

3. Analysis on curative effects and safety of 2% liranaftate ointment in treating tinea pedis and tinea corporis & cruris. (PubMed)

Analysis on curative effects and safety of 2% liranaftate ointment in treating tinea pedis and tinea corporis & cruris. The paper is intended to analyze and evaluate the specific curative effect and safety of 2% liranaftate ointment in treating patients with tinea pedis and tinea cruris. 1,100 cases of patients with tinea pedis and tinea corporis & cruris were selected as research objects and were divided into two groups according to the random number table method. They were treated (...) with different methods: 550 cases of patients were treated with 2% liranaftate ointment for external use in the observation group and the rest 550 cases of patients were treated with 1% bifonazole cream in the control group. The treatment time was two weeks for patients with tinea corporis & cruris and four weeks for those with tinea pedis respectively. Meanwhile, the one-month follow-up visit was conducted among the patients to compare the curative effects of two groups. After the medication, the curative

2017 Pakistan journal of pharmaceutical sciences

4. Comparison of dapaconazole with miconazole in the treatment of Tinea cruris. (PubMed)

Comparison of dapaconazole with miconazole in the treatment of Tinea cruris. 29888509 2019 01 18 1468-3083 33 1 2019 Jan Journal of the European Academy of Dermatology and Venereology : JEADV J Eur Acad Dermatol Venereol Comparison of dapaconazole with miconazole in the treatment of Tinea cruris. e18-e20 10.1111/jdv.15116 Gobbato A A M AAM Department of Pharmacology, Faculty of Medical Sciences, State University of Campinas (UNICAMP), Campinas, Brazil. Babadópulos T T Department of Pharmacology

2018 Journal of the European Academy of Dermatology and Venereology

5. Correlation of invitro susceptibility based on MICs and <i>SQLE</i> mutations with clinical response to terbinafine in patients with tinea corporis/cruris. (PubMed)

Correlation of invitro susceptibility based on MICs and SQLE mutations with clinical response to terbinafine in patients with tinea corporis/cruris. Recalcitrant dermatophytoses are on the rise in India. High MICs of terbinafine (TRB) and squalene epoxidase (SQLE) gene mutations conferring resistance in Trichophyton spp. have been recently documented. However, studies correlating laboratory data with clinical response to TRB in tinea corporis/cruris are lacking. For this study, we (...) investigated the clinicomycological profile of 85 tinea corporis/cruris patients and performed antifungal susceptibility testing by CLSI microbroth dilution and SQLE mutation analysis of the isolates obtained and correlated these with the responses to TRB. Patients confirmed by potassium hydroxide (KOH) mounting of skin scrapings were started on TRB at 250 mg once a day (OD). If >50% clinical clearance was achieved by 3 weeks, the same dose was continued (group 1). If response was <50%, the dose

2018 Antimicrobial Agents and Chemotherapy

6. Maximal Use of Luliconazole Cream 1% in Pediatric Patients With Moderate to Severe Tinea Pedis or Tinea Cruris

Maximal Use of Luliconazole Cream 1% in Pediatric Patients With Moderate to Severe Tinea Pedis or Tinea Cruris Maximal Use of Luliconazole Cream 1% in Pediatric Patients With Moderate to Severe Tinea Pedis or Tinea Cruris - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved (...) studies (100). Please remove one or more studies before adding more. Maximal Use of Luliconazole Cream 1% in Pediatric Patients With Moderate to Severe Tinea Pedis or Tinea Cruris The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02767271 Recruitment Status : Completed First Posted : May 10, 2016 Last

2016 Clinical Trials

7. Clinical Trial Comparing Dapaconazole Versus Miconazole in Patients With Tinea Cruris

Clinical Trial Comparing Dapaconazole Versus Miconazole in Patients With Tinea Cruris Clinical Trial Comparing Dapaconazole Versus Miconazole in Patients With Tinea Cruris - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before (...) adding more. Clinical Trial Comparing Dapaconazole Versus Miconazole in Patients With Tinea Cruris The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT03359070 Recruitment Status : Completed First Posted : December 2, 2017 Last Update Posted : December 2, 2017 Sponsor: Galeno Desenvolvimento de Pesquisas

2017 Clinical Trials

8. Tinea Cruris

Tinea Cruris Tinea Cruris Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Tinea Cruris Tinea Cruris Aka: Tinea Cruris , Jock Itch From (...) are a random sampling from a Bing search on the term "Tinea Cruris." Click on the image (or right click) to open the source website in a new browser window. Related Studies (from Trip Database) Ontology: Tinea cruris (C1384589) Concepts Disease or Syndrome ( T047 ) ICD10 SnomedCT 240697008 , 59089002 , 266216007 , 186989008 , 399029005 English Hebrae , tinea cruris , tinea cruris (diagnosis) , Ringworm of groin , Groin tinea , Groin ringworm , Dhobi itch , jock itching , Itching;jock , itching jock , Tinea

2018 FP Notebook

9. Luzu (luliconozole) - For the topical treatment of interdigital tinea pedis, tinea cruris, and tinea corporis caused by the organisms Trichophyton rubrum and Epidermophyton floccosum, in patients 18 years of age and older

Luzu (luliconozole) - For the topical treatment of interdigital tinea pedis, tinea cruris, and tinea corporis caused by the organisms Trichophyton rubrum and Epidermophyton floccosum, in patients 18 years of age and older Drug Approval Package: Brand Name (Generic Name) NDA # Drug Approval Package U.S. Food & Drug Administration Search FDA Drug Approval Package - LUZU (luliconazole) Cream Company: Medicis Pharmaceutical Corporation Application No.: 204153 Approval Date: 11/14/2013 Persons

2013 FDA - Drug Approval Package

10. A Comparative Study of Polymerase Chain Reaction-Restriction Fragment Length Polymorphism and Fungal Culture for the Evaluation of Fungal Species in Patients with Tinea Cruris (PubMed)

A Comparative Study of Polymerase Chain Reaction-Restriction Fragment Length Polymorphism and Fungal Culture for the Evaluation of Fungal Species in Patients with Tinea Cruris Tinea cruris is the second most common dermatophytosis in the world and the most common in Indonesia. The conventional laboratory tests for dermatophyte infection are slow and less specific. Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP) is a PCR method with the addition of enzyme after (...) amplification, therefore enabling for more specific results.This study aimed to find whether the PCR-RFLP test could yield the same fungal species result as a fungal culture.The specimens were skin scrapings from thirty-one patients suspected tinea cruris. The tools and materials that were used were Sabaroud's dextrose agar media, primer ITS 1 and ITS 4 and MvaI.The equation percentage of the test result species between PCR-RFLP and fungal culture was 50% of 12 subjects whose the test results were both

Full Text available with Trip Pro

2017 Open access Macedonian journal of medical sciences

11. Evidence-based topical treatments for tinea cruris and tinea corporis: a summary of a Cochrane systematic review. (PubMed)

Evidence-based topical treatments for tinea cruris and tinea corporis: a summary of a Cochrane systematic review. Tinea cruris and tinea corporis are common fungal infections. Most can be treated with a variety of topical antifungals. This review aimed to assess the evidence for the effectiveness and safety of topical treatments for tinea cruris and tinea corporis. Searches included the Cochrane Skin Group Specialised Register, CENTRAL in The Cochrane Library, Medline, Embase, LILACS

2015 British Journal of Dermatology

12. Study Evaluating the Drug Interaction Potential of Luliconazole Cream 1% in Subjects With Tinea Pedis and Tinea Cruris

Study Evaluating the Drug Interaction Potential of Luliconazole Cream 1% in Subjects With Tinea Pedis and Tinea Cruris Study Evaluating the Drug Interaction Potential of Luliconazole Cream 1% in Subjects With Tinea Pedis and Tinea Cruris - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum (...) number of saved studies (100). Please remove one or more studies before adding more. Study Evaluating the Drug Interaction Potential of Luliconazole Cream 1% in Subjects With Tinea Pedis and Tinea Cruris The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02394340 Recruitment Status : Unknown Verified

2015 Clinical Trials

13. Efficacy and safety of terbinafine hydrochloride 1% cream vs eberconazole nitrate 1% cream in localised tinea corporis and tinea cruris. (PubMed)

Efficacy and safety of terbinafine hydrochloride 1% cream vs eberconazole nitrate 1% cream in localised tinea corporis and tinea cruris. To study and compare the efficacy and safety of topical terbinafine hydrochloride 1% cream and eberconazole nitrate 1% cream in localized tinea corporis and cruris.Patients were randomized after considering various inclusion and exclusion criteria into two groups. Group A (treated with terbinafine 1% cream for 3 weeks) and group B (treated with eberconazole 1

Full Text available with Trip Pro

2014 Indian dermatology online journal

14. Efficacy and safety of oral fluconazole in the treatment of patients with tinea corporis, cruris or pedis or cutaneous candidosis : a multicentre, open, noncomparative study. (PubMed)

Efficacy and safety of oral fluconazole in the treatment of patients with tinea corporis, cruris or pedis or cutaneous candidosis : a multicentre, open, noncomparative study. The efficacy, safety, required duration of treatment, and patient preference for oral fluconazole 150 mg/week in the treatment of 521 patients with cutaneous candidosis, tinea corporis, tinea cruris or tinea pedis were assessed in an open, multicentre, noncomparative trial. Patients received weekly doses of fluconazole (...) effective in the treatment of tinea corporis, tinea cruris, tinea pedis and cutaneous candidosis. Furthermore, there was a high patient preference for oral fluconazole over previous topical therapy.

2014 Clinical drug investigation

15. A randomized, multicenter, double-blind, vehicle-controlled study evaluating the efficacy and safety of luliconazole cream 1% once daily for 7 days in patients aged ≥ 12 years with tinea cruris. (PubMed)

A randomized, multicenter, double-blind, vehicle-controlled study evaluating the efficacy and safety of luliconazole cream 1% once daily for 7 days in patients aged ≥ 12 years with tinea cruris. Tinea cruris, a pruritic superficial fungal infection of the groin, is the second most common clinical presentation for dermatophytosis.This phase 3 study evaluated the safety and efficacy of topical luliconazole cream 1% in patients with tinea cruris.483 patients were enrolled and 256 male and female (...) patients aged ≥12 years with clinically evident tinea cruris and eligible for modified intent-to-treat analysis were randomized 2:1 to receive luliconazole cream 1% (n=165) or vehicle (n=91) once daily for 7 days. Efficacy was evaluated at baseline and at days 7, 14, 21, and 28 based on mycology (potassium hydroxide, fungal culture) and clinical signs (erythema, scaling, pruritus). The primary outcome was complete clearance at day 28 (21 days posttreatment). Safety evaluations included adverse events

2014 Journal of drugs in dermatology : JDD

16. Tinea Cruris (Treatment)

Tinea Cruris (Treatment) Tinea Cruris Treatment & Management: Medical Care, Diet, Prevention Edition: No Results No Results Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. https://profreg.medscape.com/px/getpracticeprofile.do?method=getProfessionalProfile&urlCache=aHR0cHM6Ly9lbWVkaWNpbmUubWVkc2NhcGUuY29tL2FydGljbGUvMTA5MTgwNi10cmVhdG1lbnQ= processing > Tinea Cruris Treatment & Management (...) Updated: Feb 22, 2018 Author: Michael Wiederkehr, MD; Chief Editor: Dirk M Elston, MD Share Email Print Feedback Close Sections Sections Tinea Cruris Treatment Medical Care Clinical cure of an uncomplicated tinea cruris infection usually can be achieved using topical antifungal agents of the imidazole or allylamine family. [ ] Consider patients unable to use topical treatments consistently or with extensive or recalcitrant infection as candidates for systemic administration of antifungal therapy

2014 eMedicine.com

17. Tinea Cruris (Overview)

Tinea Cruris (Overview) Tinea Cruris: Background, Pathophysiology, Epidemiology Edition: No Results No Results Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. https://profreg.medscape.com/px/getpracticeprofile.do?method=getProfessionalProfile&urlCache=aHR0cHM6Ly9lbWVkaWNpbmUubWVkc2NhcGUuY29tL2FydGljbGUvMTA5MTgwNi1vdmVydmlldw== processing > Tinea Cruris Updated: Feb 22, 2018 Author (...) : Michael Wiederkehr, MD; Chief Editor: Dirk M Elston, MD Share Email Print Feedback Close Sections Sections Tinea Cruris Overview Background Tinea cruris, a pruritic superficial fungal infection of the groin and adjacent skin, is the second most common clinical presentation for dermatophytosis. Tinea cruris is a common and important clinical problem that may, at times, be a diagnostic and therapeutic challenge. Other Medscape articles on tinea infections include , , , , , , and . Next: Pathophysiology

2014 eMedicine.com

18. Tinea Cruris (Follow-up)

Tinea Cruris (Follow-up) Tinea Cruris Treatment & Management: Medical Care, Diet, Prevention Edition: No Results No Results Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. https://profreg.medscape.com/px/getpracticeprofile.do?method=getProfessionalProfile&urlCache=aHR0cHM6Ly9lbWVkaWNpbmUubWVkc2NhcGUuY29tL2FydGljbGUvMTA5MTgwNi10cmVhdG1lbnQ= processing > Tinea Cruris Treatment & Management (...) Updated: Feb 22, 2018 Author: Michael Wiederkehr, MD; Chief Editor: Dirk M Elston, MD Share Email Print Feedback Close Sections Sections Tinea Cruris Treatment Medical Care Clinical cure of an uncomplicated tinea cruris infection usually can be achieved using topical antifungal agents of the imidazole or allylamine family. [ ] Consider patients unable to use topical treatments consistently or with extensive or recalcitrant infection as candidates for systemic administration of antifungal therapy

2014 eMedicine.com

19. Tinea Cruris (Diagnosis)

Tinea Cruris (Diagnosis) Tinea Cruris: Background, Pathophysiology, Epidemiology Edition: No Results No Results Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. https://profreg.medscape.com/px/getpracticeprofile.do?method=getProfessionalProfile&urlCache=aHR0cHM6Ly9lbWVkaWNpbmUubWVkc2NhcGUuY29tL2FydGljbGUvMTA5MTgwNi1vdmVydmlldw== processing > Tinea Cruris Updated: Feb 22, 2018 Author (...) : Michael Wiederkehr, MD; Chief Editor: Dirk M Elston, MD Share Email Print Feedback Close Sections Sections Tinea Cruris Overview Background Tinea cruris, a pruritic superficial fungal infection of the groin and adjacent skin, is the second most common clinical presentation for dermatophytosis. Tinea cruris is a common and important clinical problem that may, at times, be a diagnostic and therapeutic challenge. Other Medscape articles on tinea infections include , , , , , , and . Next: Pathophysiology

2014 eMedicine.com

20. Efficacy and Safety of Terbinafine Hydrochloride 1% Cream vs. Sertaconazole Nitrate 2% Cream in Tinea Corporis and Tinea Cruris: A Comparative Therapeutic Trial. (PubMed)

Efficacy and Safety of Terbinafine Hydrochloride 1% Cream vs. Sertaconazole Nitrate 2% Cream in Tinea Corporis and Tinea Cruris: A Comparative Therapeutic Trial. To the best of our knowledge, till date no study comparing the efficacy and safety of terbinafine hydrochloride 1% cream and sertaconazole nitrate 2% cream has been done in localized tinea corporis and tinea cruris.This clinical trial was carried out to study and compare the efficacy of topical terbinafine hydrochloride 1% cream (...) and sertaconazole nitrate 2% cream in localized tinea corporis and tinea cruris and to know the adverse effects of these antifungal creams.In this prospective, single blind, randomized control trial with two arms, patient were randomized into two groups Group A (treatment with terbinafine cream) and Group B (treatment with sertaconazole cream). A total of 38 patients were enrolled for the study, 20 patients in group A and 18 patients in group B. But five patients of group A and three patients of group B were

Full Text available with Trip Pro

2013 Indian journal of dermatology

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>